- Dasari, A., Sobrero, A., Yao, J., Yoshino, T., Schelman, W., Yang, Z., et al. FRESCO-2: A global phase III study investigating the efficacy and safety of fruquintinib in metastatic colorectal cancer. Future Oncology. https://doi.org/10.2217/fon-2021-0202 (En premsa)
FRESCO-2: A global phase III study investigating the efficacy and safety of fruquintinib in metastatic colorectal cancer
on 31 de maig de 2021
with No hi ha comentaris
Deixa un comentari